LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

22nd October 2026

LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services

21st October 2026

EESTEVE CDMO STRENGTHENS ITS GLOBAL MANUFACTURING FOOTPRINT WITH A MAJOR INVESTMENT IN A NEW SITE IN CHINA

15th October 2026

Kindeva awarded up to $226 million contract to supply ATNAA autoinjectors to the Defense Logistics Agency

14th October 2026

Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations

13th October 2026

Lonza Launches Enhanced DNA-to-IND Offering, Enabling IND Readiness in as Little as Six Months for More Complex Biologics

12th October 2026

Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors

12th October 2026

Inizio Evoke Adds Leadership Bench to Accelerate Client Innovation and Growth

9th October 2026

Lonza and Onava Collaborate to Accelerate AI-Native Biologics Discovery with GS Ori-Go Vectors®

9th October 2026

Three new commercial appointments for Symbiosis to drive international growth

9th October 2026

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

8th October 2026

ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations